Markers of Glucagon Resistance Improve With Reductions in Hepatic Steatosis and Body Weight in Type 2 Diabetes.

Sasha A S KjeldsenMads N ThomsenMads J SkytteAmirsalar SamkaniMichael M RichterJan Frystyk Faidon MagkosElizaveta HansenHenrik S ThomsenJens J HolstSten MadsbadSteen B HaugaardThure KrarupNicolai J Wewer Albrechtsen

Published in: Journal of the Endocrine Society (2023)

Improvements in glucagon resistance may depend on body weight loss in patients with type 2 diabetes.

Keyphrases

body weight
type diabetes
weight loss
bariatric surgery
glycemic control
cardiovascular disease
roux en y gastric bypass
insulin resistance
gastric bypass
metabolic syndrome
obese patients